Contractors frustrated by delays in getting construction projects past regulatory agencies came out in strong support of a bill that would let the government of Guam outsource some of the permitting ...
Seres Therapeutics, Inc. is currently listed on NASDAQ under MCRB. One share of MCRB stock can currently be purchased for approximately $8.81. Is Seres Therapeutics, Inc. listed on the NASDAQ or NYSE?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results